Paid Clinical Trials Charleston
Discover 129 paid clinical trials in Charleston, West Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).
Sponsor:
Saint Francis Hospital
Location:
Code:
NCT06246526
Conditions
Pain
Chronic Pain
Neuropathic Pain
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Evoke
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate ControlRandomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control
Sponsor:
CAMC Health System
Location:
Code:
NCT02025465
Conditions
Atrial Fibrillation
Atrial Flutter
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Metoprolol
Diltiazem
Assessment of Valproate on Ethanol WithdrawalAssessment of Valproate on Ethanol Withdrawal
Sponsor:
CAMC Health System
Location:
Code:
NCT03235531
Conditions
Alcohol Dependence
Alcohol Withdrawal Syndrome
Trauma
Heavy Drinking
Alcohol Use Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Valproate
Lorazepam
Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)
Sponsor:
CAMC Health System
Location:
Code:
NCT02742974
Conditions
Critical Illness
Trauma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FloTrac™ and EV1000™
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's SarcomaCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Sponsor:
University of Leicester
Location:
Code:
NCT00020566
Conditions
Sarcoma
Eligibility Criteria
Sex: All
Age: 0 - 49
Healthy Volunteers: Not accepted
Interventions
dactinomycin
busulfan
doxorubicin hydrochloride
etoposide
ifosfamide
MFOLFIRINOX Versus MFOLFOX with or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaMFOLFIRINOX Versus MFOLFOX with or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT05677490
Conditions
Advanced Esophageal Adenocarcinoma
Advanced Gastric Adenocarcinoma
Advanced Gastroesophageal Junction Adenocarcinoma
Clinical Stage III Esophageal Adenocarcinoma AJCC V8
Clinical Stage III Gastric Cancer AJCC V8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Fluorouracil
Leucovorin Calcium
Oxaliplatin
Irinotecan
Nivolumab
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentTesting the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT06589804
Conditions
Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Hypopharyngeal Squamous Cell Carcinoma
Metastatic Laryngeal Squamous Cell Carcinoma
Metastatic Oral Cavity Squamous Cell Carcinoma
Metastatic Oropharyngeal Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Cetuximab
Computed Tomography
Magnetic Resonance Imaging
Pembrolizumab
Project: Every Child for Younger Patients With CancerProject: Every Child for Younger Patients With Cancer
Sponsor:
Children's Oncology Group
Location:
Code:
NCT02402244
Conditions
Adrenal Gland Pheochromocytoma
Carcinoma In Situ
Central Nervous System Neoplasm
Childhood Immature Teratoma
Childhood Langerhans Cell Histiocytosis
Eligibility Criteria
Sex: All
Age: 0 - 25
Healthy Volunteers: Not accepted
Interventions
Cytology Specimen Collection Procedure
Medical Chart Review
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate CancerTesting the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT04134260
Conditions
Prostate Adenocarcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage IIA Prostate Cancer AJCC v8
Stage IIB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Apalutamide
Hormone Therapy
Quality-of-Life Assessment
Questionnaire Administration
Radiation Therapy